Register
Login:
Share:
Email Facebook Twitter




SAR Share Chat - RSS Feed

Sareum Share Chat (SAR)



Share Price: 0.23Bid: 0.21Ask: 0.25Change: -0.005 (-2.13%)Faller - Sareum
Spread: 0.04Spread as %: 19.05%Open: 0.235High: 0.235Low: 0.23Yesterday’s Close: 0.235



Share Discussion for Sareum (SAR)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


Utahsaints
Posts: 331
Off Topic
Opinion:No Opinion
Price:0.58
RNS
1 Oct '14
There is an RNS by sareum who relate it to the journal and TM looks forward to discussing with future partners........

I'm not saying it's a bad RNS I'm just saying that this is not the news market is waiting so unfortunately it chips away at at price and it seems that for now I am correct

Hopefully just for now

Ps worthington on slide who didn't see that coming?
 
Fredd1eboy
Posts: 922
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.58
Surely you all must be aware...
1 Oct '14
...This board is full of derampers just after making a few quid shorting the stock. Ignore and hopefully they will get burnt when a partnership is announced and the sp recovers. In the meantime buy on the lows. Best wishes. Freddie
p's nothing personal, just business
Fidelio
Posts: 59
Off Topic
Opinion:Strong Buy
Price:0.58
Sareum is just starting!!!!!
1 Oct '14
Guys, this is just the beginning of whole bunch of good news.
Last week a new stockholder has entered the building.
We know already from others Sareums Skill platform will be worth a lot >5P so just wait and see.
kazimira
Posts: 137
Off Topic
Opinion:No Opinion
Price:0.58
Re: Motives
1 Oct '14
Where do you get the idea this is a "no news RNS"? For a start this is not an RNS, it is simply announcing a peer-reviewed journal article published today. And what's not to like about a team of scientists reporting a striking decrease in disease pathology thanks to Sareum's compound SAR-20347? To me that sounds like good news for the millions of people with psoriasis, for which there is currently no effective treatment.
Utahsaints
Posts: 331
Off Topic
Opinion:No Opinion
Price:0.58
Motives
1 Oct '14
I hold 1.7m

It's the market who decides price( meant to anyway) all I'm saying is the expectation of really good news means that a no news RNS makes the market believe that nothing really positive will happen any day soon and pushes out the pay day. Rightly or wrongly there is lots of negativity around sareum
Fredd1eboy
Posts: 922
Premium Chat Member
Answer
Opinion:Strong Buy
Price:0.58
fao. kazirira
1 Oct '14
Good call. Common sense will prevail. I've just topped up this morning at a good price. Best wishes. Freddie
kazimira
Posts: 137
Off Topic
Opinion:No Opinion
Price:0.58
Utahsaints
1 Oct '14
Taking a somewhat longer-term view than the first hour's trading, note what the Journal of Immunology says: "the administration of SAR-20347 led to a striking decrease in disease pathology". For a scientist, a phrase such as "striking decrease" is pretty exciting language!
Latino
Posts: 1,680
Off Topic
Opinion:No Opinion
Price:0.60
Utah
1 Oct '14
Why are you predicting drop? when all they have done is announce what's has been printed in the journals. I question your motives here.
Utahsaints
Posts: 331
Off Topic
Opinion:No Opinion
Price:0.58
Ok
1 Oct '14
Fair dos

Share price down today I can see this 10-15% down end of day
PHILBORO
Posts: 704
Observation
Opinion:Strong Buy
Price:0.65
R Oh!
1 Oct '14
Just saying mate, not a lot in the scheme of things but you can't say there hasn't been buying over the last week or so





Sign up for Live Prices


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.